Quintet Private Bank (Europe) S.A. Alnylam Pharmaceuticals, Inc. Transaction History

Quintet Private Bank (Europe) S.A.

  • $1.75 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$185.01 - $212.05 $241,068 - $276,301
-1,303 Reduced 51.71%
1,217 $231 Million
Q1 2023

May 12, 2023
BUY
$182.66 - $235.53 $460,303 - $593,535
2,520 New
2,520 $505 Million
Q2 2022

Aug 09, 2023
SELL
$120.42 - $169.29 $156,907 - $220,584
-1,303 Reduced 51.71%
1,217 $231 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Quintet Private Bank (Europe) S.A. Portfolio

Follow Quintet Private Bank (Europe) S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quintet Private Bank (Europe) S.A., based on Form 13F filings with the SEC.

News

Stay updated on Quintet Private Bank (Europe) S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email